Tombot, a company creating a robotic dog companion designed especially for people who cannot care for a live pet, has closed $7 million in Series A3 funding to prepare for a commercial launch this autumn. The funds will support scaling production and operations for Jennie, a robot modeled after a young Labrador puppy, aimed at easing loneliness and providing emotional care to older adults and individuals with cognitive and mental health challenges.
- Raised $7 million to fund manufacturing and launch.
- Targeting older adults and cognitive health markets.
- Over 23,000 pre-orders before first shipment.
What happened
Tombot, a Los Angeles-based startup, announced securing $7 million in a Series A3 funding round led by investors including Caduceus Capital Partners and the Lutheran Foundation for Long Term Living. This financing round is intended to transition Tombot’s flagship product Jennie from development to manufacturing and commercial release in fall 2026.
Jennie is an autonomous robotic Labrador puppy designed to replicate the behavior and companionship of a real dog, particularly aimed at individuals who cannot care for live pets. The company positions Jennie as a therapeutic companion for people living with dementia, mild cognitive impairment, anxiety, loneliness, autism, and PTSD. Tombot claims to have generated significant demand through more than 23,000 pre-orders and waitlist sign-ups ahead of the first unit shipment.
Why it matters
The funding reflects growing recognition of the challenges faced by an aging population, caregiver shortages, and the increasing prevalence of social isolation and mental health issues. Tombot’s product aims to deliver the benefits of pet companionship, such as comfort and emotional support, without the practical challenges of caring for a live animal.
Investors in this round are primarily from healthcare and aging service backgrounds rather than typical consumer tech funds, underscoring the social impact and healthcare relevance of the robotic companion. With millions globally living with cognitive and mental health conditions, Jennie represents a potential innovation at the intersection of robotics, healthcare, and eldercare technology.
What to watch next
The key milestone ahead for Tombot will be executing its planned autumn 2026 launch and converting its substantial pre-order interest into actual sales and delivered product experiences. As a hardware-first robotics startup, success depends on transitioning from prototype to reliable, scalable manufacturing and comprehensive customer support.
The market reception of Jennie will reveal whether robotic companions can achieve wide adoption in caregiving and mental health settings. Tombot’s performance in meeting production targets, managing supply, and demonstrating measurable benefits to users will be critical to establishing a sustainable business and expanding its product lineup.